InvestorsHub Logo
Followers 59
Posts 2197
Boards Moderated 4
Alias Born 04/28/2019

Re: None

Wednesday, 05/22/2019 8:01:51 PM

Wednesday, May 22, 2019 8:01:51 PM

Post# of 673
Compensated Awareness Post View Disclaimer
$MGNX 14% Afterhours Breakout on positive phase 3 results

Afterhours Macrogenics Inc has announced Positive Results from Phase 3 SOPHIA Study of Margetuximab in Patients with HER2-Positive Metastatic Breast Cancer. This has resulted in a 15% jump in price on high volume , we will looking for continuation tomorrow, this could be a flyer.


Official InvestorsHub (IHUB) Profile for TopMarketGainers.com. Since 2009,
we are the #1 Source For #FREE Winning #NASDAQ & #NYSE-Listed Alerts!

IHUB Board: https://investorshub.advfn.com/Chart-Analysis-TopMarketGainerscom-36847/

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.